menu search

Globally Recognized Expert in Rare Neurologic Diseases, Dr. Michael Levy, Joins Trethera Scientific Advisory Board

Globally Recognized Expert in Rare Neurologic Diseases, Dr. Michael Levy, Joins Trethera Scientific Advisory Board
LOS ANGELES, Sept. 05, 2023 (GLOBE NEWSWIRE) — Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of cancer and autoimmune diseases, announced today the appointment of Michael Levy, MD, PhD, to its Scientific Advisory Board. Dr. Levy will have a particular focus on evaluating the […] The post Globally Recognized Expert in Rare Neurologic Diseases, Dr. Michael Levy, Joins Trethera Scientific Adviso... Read More
Posted: Sep 5 2023, 14:55
Author Name: forextv
Views: 110619

Search within

Pages Search Results: